| Rheumatoid arthritis: pathological mechanisms and modern pharmacologic therapies |
116 |
| Paracrine and endocrine actions of bone-the functions of secretory proteins from osteoblasts, osteocytes, and osteoclasts |
55 |
| Biomimetic delivery of signals for bone tissue engineering |
42 |
| Advanced smart biomaterials and constructs for hard tissue engineering and regeneration |
40 |
| Evolving concepts in bone infection: redefining biofilm, acute vs. chronic osteomyelitis, the immune proteome and local antibiotic therapy |
38 |
| YAP promotes osteogenesis and suppresses adipogenic differentiation by regulating beta-catenin signaling |
32 |
| Transforming growth factor-beta in stem cells and tissue homeostasis |
31 |
| The art of building bone: emerging role of chondrocyte-to-osteoblast transdifferentiation in endochondral ossification |
30 |
| RANKL signaling in bone marrow mesenchymal stem cells negatively regulates osteoblastic bone formation |
29 |
| Omentin-1 prevents inflammation-induced osteoporosis by downregulating the pro-inflammatory cytokines |
27 |
| Ankylosing spondylitis: etiology, pathogenesis, and treatments |
25 |
| Collagen type II suppresses articular chondrocyte hypertrophy and osteoarthritis progression by promoting integrin beta 1-SMAD1 interaction |
20 |
| Mechanically induced Ca2+ oscillations in osteocytes release extracellular vesicles and enhance bone formation |
19 |
| Pathological mechanisms and therapeutic outlooks for arthrofibrosis |
16 |
| mTOR signaling in skeletal development and disease |
15 |
| Long noncoding RNAs: a missing link in osteoporosis |
15 |
| Super enhancer inhibitors suppress MYC driven transcriptional amplification and tumor progression in osteosarcoma |
14 |
| Exosomes-the enigmatic regulators of bone homeostasis |
14 |
| Bone loss from Wnt inhibition mitigated by concurrent alendronate therapy |
14 |
| Autophagy in bone homeostasis and the onset of osteoporosis |
13 |
| Mandible exosomal ssc-mir-133b regulates tooth development in miniature swine via endogenous apoptosis |
13 |
| Alpl prevents bone ageing sensitivity by specifically regulating senescence and differentiation in mesenchymal stem cells |
12 |
| Lrp1 in osteoblasts controls osteoclast activity and protects against osteoporosis by limiting PDGF-RANKL signaling |
12 |
| Efficacy of an orally active small-molecule inhibitor of RANKL in bone metastasis |
11 |
| Engineering 3D approaches to model the dynamic microenvironments of cancer bone metastasis |
11 |
| DMP1 prevents osteocyte alterations, FGF23 elevation and left ventricular hypertrophy in mice with chronic kidney disease |
10 |
| Extracellular vesicles from human urine-derived stem cells prevent osteoporosis by transferring CTHRC1 and OPG |
10 |
| NOTUM inhibition increases endocortical bone formation and bone strength |
10 |
| Histone demethylase LSD1 regulates bone mass by controlling WNT7B and BMP2 signaling in osteoblasts |
10 |
| The role of GPCRs in bone diseases and dysfunctions |
10 |
| Sustained Akt signaling in articular chondrocytes causes osteoarthritis via oxidative stress-induced senescence in mice |
9 |
| 50 years of scanning electron microscopy of bone-a comprehensive overview of the important discoveries made and insights gained into bone material properties in health, disease, and taphonomy |
9 |
| Activation of mTORC1 in subchondral bone preosteoblasts promotes osteoarthritis by stimulating bone sclerosis and secretion of CXCL12 |
9 |
| Osteocyte dysfunction promotes osteoarthritis through MMP13-dependent suppression of subchondral bone homeostasis |
9 |
| Inhibition of cyclooxygenase-2 activity in subchondral bone modifies a subtype of osteoarthritis |
8 |
| Ciliary parathyroid hormone signaling activates transforming growth factor-beta to maintain intervertebral disc homeostasis during aging |
8 |
| Nucleic acids and analogs for bone regeneration |
8 |
| Bench-to-bedside strategies for osteoporotic fracture: From osteoimmunology to mechanosensation |
8 |
| Mesenchymal VEGFA induces aberrant differentiation in heterotopic ossification |
7 |
| Molecularly specific detection of bacterial lipoteichoic acid for diagnosis of prosthetic joint infection of the bone |
6 |
| G alpha(s) signaling controls intramembranous ossification during cranial bone development by regulating both Hedgehog and Wnt/beta-catenin signaling |
6 |
| Erythropoietin modulates bone marrow stromal cell differentiation |
6 |
| Humanized bone facilitates prostate cancer metastasis and recapitulates therapeutic effects of zoledronic acid in vivo |
6 |
| Enhancer variants reveal a conserved transcription factor network governed by PU.1 during osteoclast differentiation |
6 |
| Controlling hypoxia-inducible factor-2 alpha is critical for maintaining bone homeostasis in mice |
5 |
| Oxidized phospholipids are ligands for LRP6 |
5 |
| Human iPSC-derived iMSCs improve bone regeneration in mini-pigs |
5 |
| BMP-IHH-mediated interplay between mesenchymal stem cells and osteoclasts supports calvarial bone homeostasis and repair |
5 |
| Aberrant activation of latent transforming growth factor-beta initiates the onset of temporomandibular joint osteoarthritis |
5 |
| IGF-I induced phosphorylation of PTH receptor enhances osteoblast to osteocyte transition |
4 |
